Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5568550

CCCCNC(=O)[C@H]1Nc2ccc3ccccc3c2C1C(=O)[C@@H](N)CC.O=C(O)C(F)(F)F

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
REN P00797 3/20 0.36
NCEH1 Q6PIU2 1/20 0.35
AR P10275 1/20 0.35
NR4A1 P22736 1/20 0.34
CXCR3 P49682 1/20 0.34
TP53 P04637 1/20 0.33
F2 P00734 2/20 0.33
F10 P00742 2/20 0.33
HPGD P15428 2/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
DRD2 P14416 1/20 0.33
DRD3 P35462 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5568717 0.94 KDM4E (0.41) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
Trifluoroacetic Acid SCHEMBL5563692 0.90 AR (0.35) KDM4EALDH1A1ARNR4A1HPGD
Trifluoroacetic Acid SCHEMBL5568744 0.86 NCEH1 (0.39) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL5568373 0.86 AR (0.38) KDM4EALDH1A1CYP1A2ARNR4A1
SCHEMBL8210869 0.80 NR4A1 (0.48) KDM4EALDH1A1CYP1A2ARNR4A1
SCHEMBL8210866 0.80 NR4A1 (0.48) KDM4EALDH1A1CYP1A2ARNR4A1
Trifluoroacetic Acid SCHEMBL8200696 0.72 KDM4E (0.39) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL5568280 0.64 CTSK (0.42) ARNR4A1
Trifluoroacetic Acid SCHEMBL9054201 0.62 NCEH1 (0.38) KDM4EALDH1A1NCEH1CXCR3F2
SCHEMBL7041603 0.60 KMT2A (0.51) KDM4EALDH1A1HPGDHSD17B10DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042288-B1 TRIPEPTIDYL PEPTIDASE INHIBITORS INST NAT SANTE RECH MED (FR) 2007-11-07 EP claimed
US-6335360-B1 INDOLINE-2-CARBOXYLIC AMIDE DERIVATIVES; OBESITY, EATING AND PSYCHOLOGICAL DISORDERS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-01-01 US claimed
EP-1042288-A1 TRIPEPTIDYL PEPTIDASE INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2000-10-11 EP claimed
WO-1999033801-A1 TRIPEPTIDYL PEPTIDASE INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1999-07-08 WO claimed
EP-1042288-B1 TRIPEPTIDYL PEPTIDASE INHIBITORS INST NAT SANTE RECH MED (FR) 2007-11-07 EP disclosed
US-6335360-B1 INDOLINE-2-CARBOXYLIC AMIDE DERIVATIVES; OBESITY, EATING AND PSYCHOLOGICAL DISORDERS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-01-01 US disclosed
EP-1042288-A1 TRIPEPTIDYL PEPTIDASE INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2000-10-11 EP disclosed
WO-1999033801-A1 TRIPEPTIDYL PEPTIDASE INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1999-07-08 WO disclosed